Physician profile
Amar R Shah
NPI 1962606509
$1,234.22
in general payments reported to CMS, 2019-2025
19 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $229 · 2021: $15.58 · 2022: $132 · 2023: $167 · 2024: $57.43 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $377.21 | 2023-2025 | Inspire |
| Intuitive Surgical, INC. | $172.60 | 2025 | |
| Abbott Laboratories | $101.56 | 2022-2024 | Freestyle Libre 3 |
| Medtronic Vascular, INC. | $101.34 | 2019 | |
| Supernus Pharmaceuticals, INC. | $94.72 | 2019-2020 | |
| Glaxosmithkline, LLC. | $92.14 | 2020 | |
| Novo Nordisk INC | $52.03 | 2019-2020 | |
| Itamar Medical INC | $38.24 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $30.75 | 2019 | |
| Sanofi Pasteur INC. | $30.19 | 2021-2022 | |
| Pfizer INC. | $25.19 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.82 | 2019 | |
| Insulet Corporation | $16.70 | 2020 | |
| Merck Sharp & Dohme LLC | $15.43 | 2019 | |
| Phadia US INC. | $15.22 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.42 | 2019 | |
| Mylan Specialty L.P. | $12.23 | 2020 | |
| Medtronic USA, INC. | $11.92 | 2019 | |
| Amarin Pharma, INC. | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.